Tuberculosis due to Mycobacterium bovis after alemtuzumab administration.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12856232.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We describe a patient with relapsing B chronic lymphocytic leukemia who developed systemic bacille Calmette-Guérin infection (BCGitis) after administration of alemtuzumab (Campath-1H).
Medical subject headings
- Antibodies, Monoclonal
- Antibodies, Neoplasm
- Antineoplastic Agents
- Mycobacterium bovis
- Tuberculosis